Bayer Pharmaceuticals' chief operating officer said the head of the top U.S. drug regulator recently reassured industry ...

Bayer has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its kidney-disease drug Kerendia in certain people with heart failure. Bayer on ...

If the FDA follows through on the panel’s recommendations, Johnson & Johnson, Bayer and other drugmakers ... which are not under review. This week’s two-day meeting was prompted by researchers ...

Bayer US Head Says FDA Chief Reassured Pharma Executives of Timely Reviews NEW YORK (Reuters) - Bayer Pharmaceuticals' chief operating officer said the head of the top U.S. drug regulator recently ...

"We're looking at an FDA and scientific review staff that is stable, engaged and meeting its deadlines," Sebastian Guth, who oversees Bayer's U.S. operations, said in an interview. Sign up here.